Fifty-four percent of young adults with early-onset type 2 diabetes achieved disease remission after six months in a clinical program combining a strict low-calorie diet with supervised resistance and endurance training, according to a study published in The Lancet Regional Health Americas. Researchers at the Research Institute of the McGill University Health Centre in Montreal and the University of Leicester tracked 96 participants aged 18 to 45 who dropped blutzuckersenkende Medikamente—blood sugar-lowering medications—within weeks of starting the trial.
Ninety-Six Young Adults Test a Combined Diet and Exercise Protocol
Type 2 diabetes typically requires lifelong medication, but researchers designed the RESET-for-Remission trial to test whether an intensive lifestyle intervention could reverse the condition in patients under 45 years old. The study enrolled 96 adults across trial sites in Montreal, Edmonton, and Leicester who lived with type 2 diabetes and obesity but did not yet take insulin. Participants averaged 38 years of age with a body mass index of 35.2, and their diabetes diagnosis averaged 2.3 years prior to enrollment. Their baseline glycated hemoglobin (HbA1c) averaged 7.2 percent, and more than three-quarters already took glucose-lowering drugs.
Investigators randomly assigned 50 participants to the active lifestyle program and 46 participants to a control group receiving standard medical care. For the first twelve weeks, participants in the program consumed 800 to 900 kilocalories daily. The first two weeks relied entirely on meal-replacement shakes and bars, followed by the addition of one conventional meal per day. Clinicians stopped all blood sugar-lowering medications at the start of the intervention.
Three Weekly Training Sessions Protect Muscle Mass During Rapid Weight Loss
Beginning in the third week, participants attended two supervised training sessions per week, which gradually increased to one hour each. These sessions split evenly between endurance work—such as walking and interval training—and resistance exercises using free weights and gym machines. Participants completed a third training session independently each week. In the study’s second half, participants transitioned to a normal, healthy weight-maintenance diet while continuing to exercise on their own.
Magnetic resonance imaging revealed that participants in the active program lost an average of 7.5 kilograms more than the control group. Organ and tissue scans showed liver fat dropped by more than nine percent and visceral belly fat surrounding organs decreased by more than 24 percent. Unlike standard rapid weight loss diets that deplete muscle mass, the RESET protocol preserved muscle volume in the abdomen and thighs while significantly reducing intramuscular fat. Handgrip strength increased, and body-weight relative fitness improved by just over ten percent.
Fifty-Four Percent Reach Remission While Control Group Sees Four Percent Success
The trial defined remission as an HbA1c level below 6.5 percent without the aid of glucose-lowering medications for at least twelve weeks. After 24 weeks, 27 of the 50 participants in the program—representing 54 percent—met these criteria. In comparison, only two participants out of 46 in the control group, or approximately four percent, achieved remission. The therapeutic effect remained consistent across genders, ethnic backgrounds, and study locations, with a 90 percent completion rate among the 96 total participants at the final examination.
Blood pressure and resting heart rates dropped, blood lipid profiles improved, and insulin resistance decreased across the active intervention group. After twelve weeks, elevated blood pressure normalized in 63 percent of program participants compared to 13 percent in the control group. At 24 weeks, the blood pressure normalization advantage remained at 56 percent versus 27 percent.
Future Research Directions Focus on Real-World Healthcare Integration
Study leaders Kaberi Dasgupta of the McGill University Health Centre and Tom Yates of the University of Leicester plan to launch a larger, longer-term trial comparing diet alone against diet combined with supervised exercise under everyday healthcare conditions. Independent researchers note that while the supervised training yielded clear metabolic gains, funding and organizing supervised exercise within standard healthcare systems remains a financial and logistical hurdle. The current findings provide early data for younger patient populations facing aggressive disease progression, though long-term durability past 24 weeks requires further observation.
Frequently Asked Questions About the RESET-for-Remission Trial
What were the primary inclusion criteria for participants in the study?
The study enrolled 96 adults between the ages of 18 and 45 who had been diagnosed with type 2 diabetes and obesity but were not yet taking insulin injections.
Which academic institutions led the clinical trial?
The research was led by investigators at the Research Institute of the McGill University Health Centre in Montreal and the University of Leicester, with trial sites operating in Montreal, Edmonton, and Leicester.
How much weight did participants lose during the active intervention?
Participants in the program lost an average of roughly 7.5 kilograms more than the individuals in the control group receiving standard medical care.
Related reading